Clover Health Reports 62% Revenue Growth to $749.2 Million in Latest Quarter

Clover Health Investments, Corp. reported significant financial growth in its latest quarterly filing, with total revenues reaching $749.2 million for the three months ended March 31, 2026, a 62% increase from $462.3 million in the same period last year. This surge was primarily driven by a 63% rise in net premiums earned, which amounted to $744.2 million, attributed to a 51% increase in average membership. The company also reported a net income of $27.3 million, a notable turnaround from a net loss of $1.3 million in the prior year.

Operating expenses also saw a substantial rise, increasing by 55.7% to $721.9 million, largely due to a 67% increase in net medical claims incurred, which totaled $589.6 million. General and administrative expenses rose by 47% to $74.6 million, reflecting higher professional and broker fees associated with the growth in membership. Despite these increased costs, Clover Health's operational efficiency improved, as evidenced by a gross profit of $159.5 million, compared to $108.9 million in the previous year.

In terms of strategic developments, Clover Health launched Counterpart Health, Inc., a new subsidiary aimed at extending its Clover Assistant technology to external Medicare Advantage payors and providers. This initiative is expected to enhance patient outcomes and reduce healthcare costs, thereby creating new growth opportunities for the company. Clover Health continues to operate its Medicare Advantage plans across five states and 203 counties, serving a total of 155,773 members as of March 31, 2026.

The company also reported a significant increase in its cash position, with cash and cash equivalents rising to $173.3 million from $78.3 million at the end of the previous fiscal year. This increase in liquidity is expected to support Clover Health's operational and regulatory requirements in the near term. The company anticipates that its current cash flow projections will be sufficient to meet its obligations over the next 12 months, although it may seek additional financing to support future growth initiatives.

Looking ahead, Clover Health remains focused on leveraging its technology to improve healthcare delivery and reduce costs for its members. The company is optimistic about its growth trajectory, driven by its expanding membership base and the successful implementation of its strategic initiatives. However, management acknowledges the inherent risks and uncertainties in the healthcare market, which could impact future performance.